AAAAAA
Results: 1-25/56
Authors:
SZEBENI J
MUGGIA FM
ALVING CR
Citation: J. Szebeni et al., COMPLEMENT ACTIVATION BY CREMOPHOR EL AS A POSSIBLE CONTRIBUTOR TO HYPERSENSITIVITY TO PACLITAXEL - AN IN-VITRO STUDY, Journal of the National Cancer Institute, 90(4), 1998, pp. 300-306
Authors:
SYNOLD TW
NEWMAN EM
CARROLL M
MUGGIA FM
GROSHEN S
JOHNSON K
DOROSHOW JH
Citation: Tw. Synold et al., CELLULAR BUT NOT PLASMA PHARMACOKINETICS OF LOMETREXOL CORRELATE WITHTHE OCCURRENCE OF CUMULATIVE HEMATOLOGICAL TOXICITY, Clinical cancer research, 4(10), 1998, pp. 2349-2355
Authors:
FORMENTI C
SKINNER S
SPICER K
COHEN D
KUTSCH D
SYMMANS K
VOLM F
MUGGIA FM
Citation: C. Formenti et al., CONCURRENT PACLITAXEL AND RADIATION IN LOCALLY ADVANCED BREAST-CANCER, European journal of cancer, 34, 1998, pp. 39-39
Authors:
OLEARY J
MUGGIA FM
Citation: J. Oleary et Fm. Muggia, CAMPTOTHECINS - A REVIEW OF THEIR DEVELOPMENT AND SCHEDULES OF ADMINISTRATION, European journal of cancer, 34(10), 1998, pp. 1500-1508
Authors:
SAFRA T
JEFFERS S
SORICH J
MUGGIA FM
Citation: T. Safra et al., GEMCITABINE PLUS CISPLATIN COMBINATION GIVEN WITH AMIFOSTINE (GAP) TOHEAVILY PRETREATED PATIENTS WITH GYNECOLOGIC AND PERITONEAL CANCERS -TOLERANCE AND ACTIVITY IN OVARIAN-CANCER, Anti-cancer drugs, 9(6), 1998, pp. 511-514
Authors:
MUGGIA FM
CONTI PS
Citation: Fm. Muggia et Ps. Conti, SEMINOMA AND SARCOIDOSIS - A CAUSE FOR FALSE-POSITIVE MEDIASTINAL UPTAKE IN PET, Annals of oncology, 9(8), 1998, pp. 924-924
Authors:
GARCIA AA
KEMPF RA
ROGERS M
MUGGIA FM
Citation: Aa. Garcia et al., A PHASE-II STUDY OF DOXIL (LIPOSOMAL DOXORUBICIN) - LACK OF ACTIVITY IN POOR-PROGNOSIS SOFT-TISSUE SARCOMAS, Annals of oncology, 9(10), 1998, pp. 1131-1133
Authors:
GARCIA AA
KERENROSENBERG S
PARIMOO D
ROGERS M
JEFFERS S
KODA R
MUGGIA FM
Citation: Aa. Garcia et al., PHASE-I AND PHARMACOLOGICAL STUDY OF ESTRAMUSTINE PHOSPHATE AND SHORTINFUSIONS OF PACLITAXEL IN WOMEN WITH SOLID TUMORS, Journal of clinical oncology, 16(9), 1998, pp. 2959-2963
Authors:
MUGGIA FM
Citation: Fm. Muggia, DOXIL IN BREAST-CANCER, Journal of clinical oncology, 16(2), 1998, pp. 811-811
Authors:
MUGGIA FM
BLESSING JA
HOMESLEY HD
SOROSKY J
Citation: Fm. Muggia et al., TOMUDEX (ZD1694, NSC639186) IN PLATINUM-PRETREATED RECURRENT EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY BY THE GYNECOLOGIC-ONCOLOGY-GROUP, Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 68-70
Authors:
MUGGIA FM
Citation: Fm. Muggia, SEVERE NEUROTOXICITY IN VINORELBINE-PACLITAXEL COMBINATIONS - RESPONSE, Journal of the National Cancer Institute, 89(1), 1997, pp. 88-88
Authors:
PUJARI MP
BARRIENTOS A
MUGGIA FM
KODA RT
Citation: Mp. Pujari et al., DETERMINATION OF HYDROXYUREA IN PLASMA AND PERITONEAL-FLUID BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical sciences and applications, 694(1), 1997, pp. 185-191
Authors:
GARCIA A
MUGGIA FM
Citation: A. Garcia et Fm. Muggia, ACTIVITY OF ANTHRACYCLINES IN REFRACTORY OVARIAN-CANCER - RECENT EXPERIENCE AND REVIEW, Cancer investigation, 15(4), 1997, pp. 329-334
Authors:
MUGGIA FM
HAINSWORTH JD
JEFFERS S
MILLER P
GROSHEN S
TAN M
ROMAN L
UZIELY B
MUDERSPACH L
GARCIA A
BURNETT A
GRECO FA
MORROW CP
PARADISO LJ
LIANG LJ
Citation: Fm. Muggia et al., PHASE-II STUDY OF LIPOSOMAL DOXORUBICIN IN REFRACTORY OVARIAN-CANCER - ANTITUMOR-ACTIVITY AND TOXICITY MODIFICATION BY LIPOSOMAL ENCAPSULATION, Journal of clinical oncology, 15(3), 1997, pp. 987-993
Authors:
MUGGIA FM
Citation: Fm. Muggia, SALVAGE TREATMENT OF OVARIAN-CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3420-3421
Authors:
CONTI PS
HORWICH T
ROMAN L
MUDERSPACH L
JEFFERS S
MORROW CP
MUGGIA FM
Citation: Ps. Conti et al., USE OF F-18 FDG AND PET IN ASSESSMENT OF MINIMAL DISEASE AFTER TREATMENT OF EPITHELIAL OVARIAN-CANCER, The Journal of nuclear medicine, 38(5), 1997, pp. 545-545
Authors:
GARCIA AA
PARIMOO D
DIMERY I
ROGERS M
JEFFERS S
MUGGIA FM
Citation: Aa. Garcia et al., TOLERANCE OF PACLITAXEL 3-HOUR INFUSION WITH AND WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR ON A BIWEEKLY SCHEDULE, Seminars in oncology, 24(6), 1997, pp. 62-66
Authors:
KERENROSENBERG S
MUGGIA FM
Citation: S. Kerenrosenberg et Fm. Muggia, RESPONSE TO ESTRAMUSTINE PHOSPHATE AND PACLITAXEL IN PATIENTS WITH ADVANCED BREAST-CANCER - A PHASE-I STUDY, Seminars in oncology, 24(1), 1997, pp. 26-29
Authors:
MUGGIA FM
JEFFERS S
MUDERSPACH L
ROMAN L
ROSALES R
GROSHEN S
SAFRA T
MORROW CP
Citation: Fm. Muggia et al., PHASE I II STUDY OF INTRAPERITONEAL FLOXURIDINE AND PLATINUMS (CISPLATIN AND/OR CARBOPLATIN)/, Gynecologic oncology, 66(2), 1997, pp. 290-294
Authors:
MUDERSPACH LI
CURTIN JP
ROMAN LD
GEBHARDT JA
KLEMENT V
QIAN DJ
MORROW CP
FELIX JC
FORMENTI SC
MUGGIA FM
Citation: Li. Muderspach et al., CARBOPLATIN AS A RADIATION SENSITIZER IN LOCALLY ADVANCED CERVICAL-CANCER - A PILOT-STUDY, Gynecologic oncology, 65(2), 1997, pp. 336-342
Authors:
MUGGIA FM
Citation: Fm. Muggia, CLINICAL EFFICACY AND PROSPECTS FOR USE OF PEGYLATED LIPOSOMAL DOXORUBICIN IN THE TREATMENT OF OVARIAN AND BREAST CANCERS, Drugs, 54, 1997, pp. 22-29
Authors:
MUGGIA FM
SYNOLD TW
NEWMAN EM
JEFFERS S
LEICHMAN LP
DOROSHOW JH
JOHNSON K
GROSHEN S
Citation: Fm. Muggia et al., FAILURE OF PRETREATMENT WITH INTRAVENOUS FOLIC-ACID TO ALTER THE CUMULATIVE HEMATOLOGIC TOXICITY OF LOMETREXOL, Journal of the National Cancer Institute, 88(20), 1996, pp. 1495-1496
Authors:
PARIMOO D
JEFFERS S
MUGGIA FM
Citation: D. Parimoo et al., SEVERE NEUROTOXICITY FROM VINORELBINE-PACLITAXEL COMBINATIONS, Journal of the National Cancer Institute, 88(15), 1996, pp. 1079-1080
Authors:
SYNOLD TW
XI BX
NEWMAN EM
MUGGIA FM
DOROSHOW JH
Citation: Tw. Synold et al., SIMPLE AND SENSITIVE METHOD FOR THE QUANTITATIVE-ANALYSIS OF LOMETREXOL IN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical applications, 683(2), 1996, pp. 245-249
Authors:
MUGGIA FM
WU XY
SPICER D
GROSHEN S
JEFFERS S
LEICHMAN CG
LEICHMAN L
CHAN KK
Citation: Fm. Muggia et al., PHASE-I AND PHARMACOKINETIC STUDY OF ORAL UFT, A COMBINATION OF THE 5-FLUOROURACIL PRODRUG TEGAFUR AND URACIL, Clinical cancer research, 2(9), 1996, pp. 1461-1467